Skip to content
Stock screener

UPC Universe Pharmaceuticals INC stock chart & analysis

Conviction 45HealthcareScan · Tue, Nov 17, 2026

Universe Pharmaceuticals INC (UPC) closed at $1.48 (+0.00%) on Nov 17, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 27, RS Rating 16, -91.8% from its 52-week high, -61.2% year to date. Sector: Healthcare.

UPC$1.48+0.00%
ResistanceSupportVol 14
Loading chart…

Why UPC moved

From the StockSetups movers recaps that covered UPC, newest first. A recap states what was known that day.

Universe Pharmaceuticals INCwww.universe-pharmacy.com ↗
Price1.48
Change+0.00%
Gap+2.36%
Rel volume0.07×
Avg volume189.29K
Avg $ vol409.73K
SMA 202.05
SMA 503.44
SMA 2003.65
Price vs 50-56.97%
Price vs 200-59.46%
MA stackbearish
50/200 crossdeath · 4d
Supertrenddown · 2.23
RSI (14)27
MACD hist0.05
MACD crossbull · 2d
Stoch %K / %D25 / 16
ADX (14)34
+DI / −DI16 / 32
RSI divergence—
MACD divergence—
ATR %19.77%
ADR %16.89%
52w high17.96
52w low1.33
From 52w high-91.76%
Above 52w low+11.28%
New 52w highNo
SqueezeOff
Bollinger width196.94%
%B0.36
Donchian pos4.50%
Donchian high4.66
Donchian low1.33
AVWAP (52w high)9.23
vs AVWAP high-83.97%
AVWAP (52w low)1.51
vs AVWAP low-2.15%
OBV trendDown
Chaikin MF (20)-0.55
Today vs 20d0.07×
Avg vol (14d)150.53K
Avg vol (20d)189.29K
Avg $ vol (20d)409.73K
Market cap833.74K
RS Rating16 / 99
RS 3m (vs SPY)-67.52%
RS 6m (vs SPY)-41.56%
RS line new highNo
Trend template1/8
Technical rank9.6
1 week-4.52%
1 month-60.64%
3 months-72.28%
6 months-41.73%
1 year-59.45%
YTD-61.15%
P/E—
P/B0.00
P/S—
P/FCF—
EPS—
Div yield—
ROE—
ROA—
Debt/Eq0.04
Current4.07
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth—
Price target—
Target upside—
Analyst rating—
Institutional6.65%
Ent. value-31.48B
Revenue—
Net income—
Gross profit—
Free cash flow—
Industry—
ExchangeNasdaq
Shares out—
Employees216
ListedTue, Mar 23, 2021
Free float563.34K
Float %100.0%
Short interest—
Days to cover—
Short volume20.3%
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction45 / 100
Pattern quality—
Tech rank9.6 / 100
Group rank14 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance4.83
Support1.38
Days since event—
Candle confirm—

UPC technical analysis

Trend

UPC is in a downtrend: price is below the 50-day, which is below the 200-day moving average. It closed 57.0% below the 50-day ($3.44) and 59.5% below the 200-day ($3.65). The 50-day crossed below the 200-day (a death cross) 4 sessions ago. ADX(14) at 34 points to a strong, established trend. It meets 1 of 8 trend-template criteria.

Momentum

RSI(14) is 27, in oversold territory. MACD crossed above its signal line 2 sessions ago. Its RS Rating of 16 puts its weighted 12-month performance ahead of about 16% of the US market.

Volume and volatility

Volume on the latest session ran 0.1× its 20-day average. It trades about $409,734 a day on average. ATR(14) is $0.2926, 19.8% of price — its typical daily range. On-balance volume is trending down. Chaikin Money Flow (-0.55) shows distribution.

Key levels

The chart pattern's support is $1.38 and its resistance $4.83. The 52-week range is $1.33 to $17.96; price is 91.8% below the high and 11.3% above the low. The VWAP anchored at the 52-week high is $9.23, above price.

Performance

UPC returned -4.5% (1 week), -60.6% (1 month), -72.3% (3 months), -41.7% (6 months), -59.5% (1 year), -61.2% (year to date).

About Universe Pharmaceuticals INC

Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.

Listed 2021 · 216 employees

Insider activity

SEC Form 4 transactions in UPC

InsiderSideShares
Lai Gang
Chief Executive Officer · Class A ordinary shares, par value US$0.00001 per share · 2026-05-07
Grant71.89K
Lai Gang
Chief Executive Officer · Class B ordinary shares, par value US$0.00001 per share · 2026-05-07
Grant12.61K
Lai Gang
Chief Executive Officer · Class B ordinary shares, par value US$0.00001 per share · 2026-05-07
Other—

SEC filings

EDGAR filings in UPC · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, no credit card.

Start free — 7-day trial, no card →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.